406
Participants
Start Date
October 31, 2007
Primary Completion Date
April 21, 2014
Study Completion Date
August 30, 2022
Paclitaxel
Every week for 12 weeks
Trastuzumab
Once a week for twelve weeks Then once a week or once every three weeks for 40 weeks
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medical College, New York
North Shore LIJ Health System Monter Cancer Center, Lake Success
John Hopkins University, Baltimore
University of North Carolina at Chapel Hill, Chapel Hill
Duke Comprehensive Cancer Center, Durham
Tennessee Oncology, Nashville
Case Western University, Cleveland
Indiana University, Indianapolis
Loyola University Medical Center, Maywood
Washington University, St Louis
University of California-San Francisco, San Francisco
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana-Farber at Faulkner Hospital, Boston
Dana-Farber Cancer Institute, Boston
Cape Cod Healthcare, Hyannis
Lowell General Hospital, Lowell
North Shore Medical Center, Peabody
University of Vermont Cancer Center, Burlington
Collaborators (1)
Brigham and Women's Hospital
OTHER
Beth Israel Deaconess Medical Center
OTHER
Massachusetts General Hospital
OTHER
Genentech, Inc.
INDUSTRY
Dana-Farber Cancer Institute
OTHER